APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Arterial Hypertension Equipment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pulmonary Arterial Hypertension Equipment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026199 pages

Choose your research edition.

Industry ResearchPulmonary Arterial Hypertension Equipment Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Arterial Hypertension Equipment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Pulmonary Arterial Hypertension Equipment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Arterial Hypertension Equipment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Arterial Hypertension Equipment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Pulmonary Arterial Hypertension Equipment market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pulmonary Arterial Hypertension Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pulmonary Arterial Hypertension Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pulmonary Arterial Hypertension Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pulmonary Arterial Hypertension Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pulmonary Arterial Hypertension Equipment include Medtronic, V-Wave Ltd, Swan-Ganz, SoniVie, Smiths Medical, Pulnovo Medical (Wuxi) Co.,Ltd., Philips, Nonin Medical and Masimo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pulmonary Arterial Hypertension Equipment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pulmonary Arterial Hypertension Equipment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pulmonary Arterial Hypertension Equipment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pulmonary Arterial Hypertension Equipment market size, projected growth trends, production technologies, key applications, and end-use industries.

Pulmonary Arterial Hypertension Equipment Segment by Company

Medtronic

V-Wave Ltd

Swan-Ganz

SoniVie

Smiths Medical

Pulnovo Medical (Wuxi) Co.,Ltd.

Philips

Nonin Medical

Masimo

GE Healthcare

Aria CV

Pulmonary Arterial Hypertension Equipment Segment by Type

Diagnostic Equipment

Treatment Equipment

Pulmonary Arterial Hypertension Equipment Segment by Application

Home Care

Hospital

Clinic

Pulmonary Arterial Hypertension Equipment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Arterial Hypertension Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Arterial Hypertension Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Arterial Hypertension Equipment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pulmonary Arterial Hypertension Equipment market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pulmonary Arterial Hypertension Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pulmonary Arterial Hypertension Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pulmonary Arterial Hypertension Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pulmonary Arterial Hypertension Equipment Industry Trends Table 2. Pulmonary Arterial Hypertension Equipment Industry Drivers Table 3. Pulmonary Arterial Hypertension Equipment Industry Opportunities and Challenges Table 4. Pulmonary Arterial Hypertension Equipment Industry Restraints Table 5. Global Pulmonary Arterial Hypertension Equipment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pulmonary Arterial Hypertension Equipment Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Manufacturers Table 9. Global Pulmonary Arterial Hypertension Equipment Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Pulmonary Arterial Hypertension Equipment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pulmonary Arterial Hypertension Equipment Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pulmonary Arterial Hypertension Equipment Manufacturers, Product Type & Application Table 13. Global Pulmonary Arterial Hypertension Equipment Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pulmonary Arterial Hypertension Equipment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Diagnostic Equipment Table 17. Major Manufacturers of Treatment Equipment Table 18. Global Pulmonary Arterial Hypertension Equipment Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2026) & (k units) Table 20. Global Pulmonary Arterial Hypertension Equipment Sales by Type (2027-2032) & (k units) Table 21. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type (2021-2026) Table 22. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type (2027-2032) Table 23. Global Pulmonary Arterial Hypertension Equipment Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2026) & (k units) Table 25. Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2027-2032) & (k units) Table 26. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type (2021-2026) Table 27. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Home Care Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Global Pulmonary Arterial Hypertension Equipment Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2026) & (k units) Table 33. Global Pulmonary Arterial Hypertension Equipment Sales by Application (2027-2032) & (k units) Table 34. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application (2021-2026) Table 35. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application (2027-2032) Table 36. Global Pulmonary Arterial Hypertension Equipment Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2026) & (k units) Table 38. Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2027-2032) & (k units) Table 39. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application (2021-2026) Table 40. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application (2027-2032) Table 41. Global Pulmonary Arterial Hypertension Equipment Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Pulmonary Arterial Hypertension Equipment Sales by Region (2021-2026) & (k units) Table 43. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Region (2021-2026) Table 44. Global Pulmonary Arterial Hypertension Equipment Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Pulmonary Arterial Hypertension Equipment Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Pulmonary Arterial Hypertension Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2026) & (k units) Table 48. North America Pulmonary Arterial Hypertension Equipment Sales by Country (2027-2032) & (k units) Table 49. Europe Pulmonary Arterial Hypertension Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2026) & (k units) Table 51. Europe Pulmonary Arterial Hypertension Equipment Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Pulmonary Arterial Hypertension Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Pulmonary Arterial Hypertension Equipment Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Pulmonary Arterial Hypertension Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Pulmonary Arterial Hypertension Equipment Sales by Country (2027-2032) & (k units) Table 58. Global Pulmonary Arterial Hypertension Equipment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Pulmonary Arterial Hypertension Equipment Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Pulmonary Arterial Hypertension Equipment Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Region (2021-2026) Table 62. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Region (2027-2032) Table 63. Medtronic Company Information Table 64. Medtronic Business Overview Table 65. Medtronic Pulmonary Arterial Hypertension Equipment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Medtronic Pulmonary Arterial Hypertension Equipment Product Portfolio Table 67. Medtronic Recent Development Table 68. V-Wave Ltd Company Information Table 69. V-Wave Ltd Business Overview Table 70. V-Wave Ltd Pulmonary Arterial Hypertension Equipment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. V-Wave Ltd Pulmonary Arterial Hypertension Equipment Product Portfolio Table 72. V-Wave Ltd Recent Development Table 73. Swan-Ganz Company Information Table 74. Swan-Ganz Business Overview Table 75. Swan-Ganz Pulmonary Arterial Hypertension Equipment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Swan-Ganz Pulmonary Arterial Hypertension Equipment Product Portfolio Table 77. Swan-Ganz Recent Development Table 78. SoniVie Company Information Table 79. SoniVie Business Overview Table 80. SoniVie Pulmonary Arterial Hypertension Equipment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. SoniVie Pulmonary Arterial Hypertension Equipment Product Portfolio Table 82. SoniVie Recent Development Table 83. Smiths Medical Company Information Table 84. Smiths Medical Business Overview Table 85. Smiths Medical Pulmonary Arterial Hypertension Equipment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Smiths Medical Pulmonary Arterial Hypertension Equipment Product Portfolio Table 87. Smiths Medical Recent Development Table 88. Pulnovo Medical (Wuxi) Co.,Ltd. Company Information Table 89. Pulnovo Medical (Wuxi) Co.,Ltd. Business Overview Table 90. Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Product Portfolio Table 92. Pulnovo Medical (Wuxi) Co.,Ltd. Recent Development Table 93. Philips Company Information Table 94. Philips Business Overview Table 95. Philips Pulmonary Arterial Hypertension Equipment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Philips Pulmonary Arterial Hypertension Equipment Product Portfolio Table 97. Philips Recent Development Table 98. Nonin Medical Company Information Table 99. Nonin Medical Business Overview Table 100. Nonin Medical Pulmonary Arterial Hypertension Equipment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Nonin Medical Pulmonary Arterial Hypertension Equipment Product Portfolio Table 102. Nonin Medical Recent Development Table 103. Masimo Company Information Table 104. Masimo Business Overview Table 105. Masimo Pulmonary Arterial Hypertension Equipment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Masimo Pulmonary Arterial Hypertension Equipment Product Portfolio Table 107. Masimo Recent Development Table 108. GE Healthcare Company Information Table 109. GE Healthcare Business Overview Table 110. GE Healthcare Pulmonary Arterial Hypertension Equipment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. GE Healthcare Pulmonary Arterial Hypertension Equipment Product Portfolio Table 112. GE Healthcare Recent Development Table 113. Aria CV Company Information Table 114. Aria CV Business Overview Table 115. Aria CV Pulmonary Arterial Hypertension Equipment Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Aria CV Pulmonary Arterial Hypertension Equipment Product Portfolio Table 117. Aria CV Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Pulmonary Arterial Hypertension Equipment Distributors List Table 121. Pulmonary Arterial Hypertension Equipment Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Pulmonary Arterial Hypertension Equipment Product Image Figure 2. Global Pulmonary Arterial Hypertension Equipment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pulmonary Arterial Hypertension Equipment Market Size (2021-2032) & (US$ Million) Figure 4. Global Pulmonary Arterial Hypertension Equipment Sales (2021-2032) & (k units) Figure 5. Global Pulmonary Arterial Hypertension Equipment Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pulmonary Arterial Hypertension Equipment Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Diagnostic Equipment Image Figure 9. Treatment Equipment Image Figure 10. Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Pulmonary Arterial Hypertension Equipment Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type (2021-2032) Figure 13. Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type (2021-2032) Figure 16. Home Care Image Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Pulmonary Arterial Hypertension Equipment Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application (2021-2032) Figure 22. Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application (2021-2032) Figure 25. North America Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Pulmonary Arterial Hypertension Equipment Sales Market Share by Country (2021-2032) Figure 27. U.S. Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Pulmonary Arterial Hypertension Equipment Sales Market Share by Country (2021-2032) Figure 32. Germany Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Pulmonary Arterial Hypertension Equipment Sales Market Share by Country (2021-2032) Figure 39. China Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Pulmonary Arterial Hypertension Equipment Sales Market Share by Country (2021-2032) Figure 47. Brazil Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Pulmonary Arterial Hypertension Equipment Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Pulmonary Arterial Hypertension Equipment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Figure 58. North America Pulmonary Arterial Hypertension Equipment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Figure 60. Europe Pulmonary Arterial Hypertension Equipment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Pulmonary Arterial Hypertension Equipment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Pulmonary Arterial Hypertension Equipment Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Pulmonary Arterial Hypertension Equipment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Pulmonary Arterial Hypertension Equipment Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Pulmonary Arterial Hypertension Equipment Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Equipment
  • Treatment Equipment
Applications
  • Home Care
  • Hospital
  • Clinic
Companies covered
  • Medtronic
  • V-Wave Ltd
  • Swan-Ganz
  • SoniVie
  • Smiths Medical
  • Pulnovo Medical (Wuxi) Co.,Ltd.
  • Philips
  • Nonin Medical
  • Masimo
  • GE Healthcare
  • Aria CV

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pulmonary Arterial Hypertension Equipment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pulmonary Arterial Hypertension Equipment Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pulmonary Arterial Hypertension Equipment Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pulmonary Arterial Hypertension Equipment Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pulmonary Arterial Hypertension Equipment Market Dynamics
  1. 2.1 Pulmonary Arterial Hypertension Equipment Industry Trends
  2. 2.2 Pulmonary Arterial Hypertension Equipment Industry Drivers
  3. 2.3 Pulmonary Arterial Hypertension Equipment Industry Opportunities and Challenges
  4. 2.4 Pulmonary Arterial Hypertension Equipment Industry Restraints
3 Pulmonary Arterial Hypertension Equipment Market by Manufacturers
  1. 3.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pulmonary Arterial Hypertension Equipment Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pulmonary Arterial Hypertension Equipment Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pulmonary Arterial Hypertension Equipment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pulmonary Arterial Hypertension Equipment Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pulmonary Arterial Hypertension Equipment Manufacturers, Product Type & Application
  7. 3.7 Global Pulmonary Arterial Hypertension Equipment Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pulmonary Arterial Hypertension Equipment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pulmonary Arterial Hypertension Equipment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pulmonary Arterial Hypertension Equipment Tier 1, Tier 2, and Tier 3
4 Pulmonary Arterial Hypertension Equipment Market by Type
  1. 4.1 Pulmonary Arterial Hypertension Equipment Type Introduction
  2. 4.1.1 Diagnostic Equipment
  3. 4.1.2 Treatment Equipment
  4. 4.2 Global Pulmonary Arterial Hypertension Equipment Sales by Type
  5. 4.2.1 Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2032)
  7. 4.2.3 Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pulmonary Arterial Hypertension Equipment Revenue by Type
  9. 4.3.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2032)
  11. 4.3.3 Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type (2021-2032)
5 Pulmonary Arterial Hypertension Equipment Market by Application
  1. 5.1 Pulmonary Arterial Hypertension Equipment Application Introduction
  2. 5.1.1 Home Care
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Pulmonary Arterial Hypertension Equipment Sales by Application
  6. 5.2.1 Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2032)
  8. 5.2.3 Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pulmonary Arterial Hypertension Equipment Revenue by Application
  10. 5.3.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2032)
  12. 5.3.3 Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application (2021-2032)
6 Global Pulmonary Arterial Hypertension Equipment Sales by Region
  1. 6.1 Global Pulmonary Arterial Hypertension Equipment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pulmonary Arterial Hypertension Equipment Sales by Region (2021-2032)
  3. 6.2.1 Global Pulmonary Arterial Hypertension Equipment Sales by Region (2021-2026)
  4. 6.2.2 Global Pulmonary Arterial Hypertension Equipment Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pulmonary Arterial Hypertension Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pulmonary Arterial Hypertension Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pulmonary Arterial Hypertension Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pulmonary Arterial Hypertension Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pulmonary Arterial Hypertension Equipment Revenue by Region
  1. 7.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Region
  2. 7.1.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pulmonary Arterial Hypertension Equipment Revenue by Region (2021-2026)
  4. 7.1.3 Global Pulmonary Arterial Hypertension Equipment Revenue by Region (2027-2032)
  5. 7.1.4 Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pulmonary Arterial Hypertension Equipment Revenue (2021-2032)
  8. 7.2.2 North America Pulmonary Arterial Hypertension Equipment Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pulmonary Arterial Hypertension Equipment Revenue (2021-2032)
  11. 7.3.2 Europe Pulmonary Arterial Hypertension Equipment Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pulmonary Arterial Hypertension Equipment Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pulmonary Arterial Hypertension Equipment Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pulmonary Arterial Hypertension Equipment Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pulmonary Arterial Hypertension Equipment Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Pulmonary Arterial Hypertension Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Pulmonary Arterial Hypertension Equipment Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 V-Wave Ltd
  8. 8.2.1 V-Wave Ltd Company Information
  9. 8.2.2 V-Wave Ltd Business Overview
  10. 8.2.3 V-Wave Ltd Pulmonary Arterial Hypertension Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 V-Wave Ltd Pulmonary Arterial Hypertension Equipment Product Portfolio
  12. 8.2.5 V-Wave Ltd Recent Developments
  13. 8.3 Swan-Ganz
  14. 8.3.1 Swan-Ganz Company Information
  15. 8.3.2 Swan-Ganz Business Overview
  16. 8.3.3 Swan-Ganz Pulmonary Arterial Hypertension Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Swan-Ganz Pulmonary Arterial Hypertension Equipment Product Portfolio
  18. 8.3.5 Swan-Ganz Recent Developments
  19. 8.4 SoniVie
  20. 8.4.1 SoniVie Company Information
  21. 8.4.2 SoniVie Business Overview
  22. 8.4.3 SoniVie Pulmonary Arterial Hypertension Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SoniVie Pulmonary Arterial Hypertension Equipment Product Portfolio
  24. 8.4.5 SoniVie Recent Developments
  25. 8.5 Smiths Medical
  26. 8.5.1 Smiths Medical Company Information
  27. 8.5.2 Smiths Medical Business Overview
  28. 8.5.3 Smiths Medical Pulmonary Arterial Hypertension Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Smiths Medical Pulmonary Arterial Hypertension Equipment Product Portfolio
  30. 8.5.5 Smiths Medical Recent Developments
  31. 8.6 Pulnovo Medical (Wuxi) Co.,Ltd.
  32. 8.6.1 Pulnovo Medical (Wuxi) Co.,Ltd. Company Information
  33. 8.6.2 Pulnovo Medical (Wuxi) Co.,Ltd. Business Overview
  34. 8.6.3 Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Product Portfolio
  36. 8.6.5 Pulnovo Medical (Wuxi) Co.,Ltd. Recent Developments
  37. 8.7 Philips
  38. 8.7.1 Philips Company Information
  39. 8.7.2 Philips Business Overview
  40. 8.7.3 Philips Pulmonary Arterial Hypertension Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Philips Pulmonary Arterial Hypertension Equipment Product Portfolio
  42. 8.7.5 Philips Recent Developments
  43. 8.8 Nonin Medical
  44. 8.8.1 Nonin Medical Company Information
  45. 8.8.2 Nonin Medical Business Overview
  46. 8.8.3 Nonin Medical Pulmonary Arterial Hypertension Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nonin Medical Pulmonary Arterial Hypertension Equipment Product Portfolio
  48. 8.8.5 Nonin Medical Recent Developments
  49. 8.9 Masimo
  50. 8.9.1 Masimo Company Information
  51. 8.9.2 Masimo Business Overview
  52. 8.9.3 Masimo Pulmonary Arterial Hypertension Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Masimo Pulmonary Arterial Hypertension Equipment Product Portfolio
  54. 8.9.5 Masimo Recent Developments
  55. 8.10 GE Healthcare
  56. 8.10.1 GE Healthcare Company Information
  57. 8.10.2 GE Healthcare Business Overview
  58. 8.10.3 GE Healthcare Pulmonary Arterial Hypertension Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GE Healthcare Pulmonary Arterial Hypertension Equipment Product Portfolio
  60. 8.10.5 GE Healthcare Recent Developments
  61. 8.11 Aria CV
  62. 8.11.1 Aria CV Company Information
  63. 8.11.2 Aria CV Business Overview
  64. 8.11.3 Aria CV Pulmonary Arterial Hypertension Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Aria CV Pulmonary Arterial Hypertension Equipment Product Portfolio
  66. 8.11.5 Aria CV Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pulmonary Arterial Hypertension Equipment Value Chain Analysis
  2. 9.1.1 Pulmonary Arterial Hypertension Equipment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pulmonary Arterial Hypertension Equipment Production Mode & Process
  6. 9.2 Pulmonary Arterial Hypertension Equipment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pulmonary Arterial Hypertension Equipment Distributors
  9. 9.2.3 Pulmonary Arterial Hypertension Equipment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst